NFE2L2 and Other metabolic disease: Therefore, it is reasonable to believe that obesity or diabetes caused by metabolic disorders inhibits AMPK-Nrf2 pathway activity, just as free fatty acid accumulation and high glucose environment are accompanied with oxidative stress damage and ROS accumulation (145).